Biomark Diagnostics Inc. (BUX:CSE) closed at $0.490 on October 15, 2026, down 3.92% on the day. The stock trades 23.4% below its 52-week high of $0.640 and 55.6% above its 52-week low of $0.315. Over the past year, it gained 54.5%. Biomark Diagnostics Inc. is part of the Life Sciences sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -3.77% | +2.00% | -7.27% | -12.07% | +54.55% |
In 252 trading sessions since October 14, 2025, BUX closed higher on 61 days (24%). Its best day was December 1, 2025 (+17.50%) and its worst was August 20, 2026 (-13.79%). The stock moved 10% or more in a single session 8 times. It opened at least 5% above the previous day's high 2 times.
Biomark Diagnostics Inc is an oncology focused company. The Company is engaged in developing commercialization avenues for cancer detection and monitoring business.
Find more stocks like BUX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.